Literature DB >> 23664880

Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.

Leyi Gong1, Xiaochun Han, Tania Silva, Yun-Chou Tan, Bindu Goyal, Parch Tivitmahaisoon, Alejandra Trejo, Wylie Palmer, Heather Hogg, Alam Jahagir, Muzaffar Alam, Paul Wagner, Karin Stein, Lubov Filonova, Brad Loe, Ferenc Makra, David Rotstein, Lubica Rapatova, James Dunn, Fengrong Zuo, Joseph Dal Porto, Brian Wong, Sue Jin, Alice Chang, Patricia Tran, Gary Hsieh, Linghao Niu, Ada Shao, Deborah Reuter, Johaness Hermann, Andreas Kuglstatter, David Goldstein.   

Abstract

A novel series of indole/indazole-aminopyrimidines was designed and synthesized with an aim to achieve optimal potency and selectivity for the c-Jun kinase family or JNKs. Structure guided design was used to optimize the series resulting in a significant potency improvement. The best compound (17) has IC50 of 3 nM for JNK1 and 20 nM for JNK2, with greater than 40-fold selectivity against other kinases with good physicochemical and pharmacokinetic properties.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664880     DOI: 10.1016/j.bmcl.2013.04.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  A simple and facile synthesis of tricyclic-fused pyrimido[4,5-b]indol-2-amines.

Authors:  Wentao Gao; Dongfang Wang; Yang Li
Journal:  Mol Divers       Date:  2017-06-19       Impact factor: 2.943

2.  Discovery of Novel c-Jun N-Terminal Kinase 1 Inhibitors from Natural Products: Integrating Artificial Intelligence with Structure-Based Virtual Screening and Biological Evaluation.

Authors:  Ruoqi Yang; Guiping Zhao; Bin Yan
Journal:  Molecules       Date:  2022-09-22       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.